ZANZIBAR: ZANZIBAR President Dr Hussein Mwinyi is expected to grace the Global Investors on Health and Technology meeting in Dar es Salaam on Monday.
The meeting will discuss the role of investors in changing the future of cancer care in Africa.
The forum is co-organised by the Ministry of Health, the Embassy of Tanzania in the US, and the US-based Global Health Catalyst (GHC). A press statement circulated in the media confirmed that President Mwinyi will open the forum.
The forum aims to provide potential domestic and foreign investors, as well as intermediaries, with information and opportunities for investment and collaboration.
It follows the launch of the Lancet Oncology Commission for sub-Saharan Africa in Tanzania in September 2022, the Tanzania-USA collaboration meeting in Washington DC in December 2022, and the GHC summit held at the University of Pennsylvania in May 2023, which aimed to extend the USA Cancer Moonshot globally.
The forum, which coincides with World Cancer Day on February 4, highlights the government’s commitment to advancing healthcare and development. It also emphasises the importance of collaboration with the USA and other local and international stakeholders.
The forum will provide a platform for professionals and business communities in Tanzania, Africa, and global investors in the health sector to work together to strengthen cancer care, education, and research. The ultimate goal is to end suffering from cancer in Africa.
Tanzania and the US will strengthen their commitments to the fight against cancer by establishing the Tanzania – USA Regional Advanced Cancer Centre of Excellence (TRACCE). This state-of-the-art facility will cater to Sub-Saharan Africa and focus on cancer care, education, innovation, and research.
During the forum, Tanzania will seek new partnerships with other stakeholders in cancer care and innovation. The Bankable Document for Expansion of Cancer Care in Tanzania will be presented, highlighting potential investment opportunities in the fight against cancer.
The one-day event will be attended by representatives from the private sectors of Tanzania mainland and Zanzibar, investors through the Tanzania Private Sectors Foundation (TPSF), as well as US companies such as Varian, Elekta, LTN Pharmaceuticals, Hurone AI, and Nanocan Therapeutic.
Global health leaders from leading USA institutions, including Johns Hopkins, Harvard, University of Pennsylvania, and MD Anderson Cancer Centre, will also participate. Foundations and non-profit organisation leaders focused on partnerships and investments in TRACCE will be in attendance as well.
President Mwinyi will open the investors forum with remarks on the future of cancer care in the region. His opening speech will be preceded by remarks from Health Ministers and Permanent Secretaries.
Representatives from the White House Cancer Moonshot initiative will also give remarks. Presentations from the Ministry of Health-Tanzania on the magnitude of cancer in Tanzania and GHC on the establishment of TRACCE will follow.
Investors will have the opportunity to express their interests in the field of cancer care. They will also participate in a panel discussion and breakout sessions focusing on four thematic areas: Clinical Care, Education/Training, Research, and Outreach Services. These sessions will allow investors, professionals, civil societies, and individuals with lived experiences to discuss key areas of collaboration in-depth.